|
hepatocellular carcinoma |
21 |
|
extracellular vesicles |
16 |
|
nidogen 1 |
15 |
|
neutralizing antibody |
14 |
|
intercellular communication |
13 |
|
tumor microenvironment |
12 |
|
diabetes |
11 |
|
myocardial ischemia injury |
11 |
|
pre‐metastatic niche |
11 |
|
tumor necrosis factor receptor 1 |
11 |
|
liver cancer |
10 |
|
proteomics |
10 |
|
small extracellular vesicles |
9 |
|
therapeutics |
9 |
|
adiponectin |
8 |
|
antioxidants |
8 |
|
galectin-1 |
8 |
|
glycolysis |
8 |
|
jak2/stat3 |
8 |
|
mir-22 |
8 |
|
otx008 |
8 |
|
pi3k/akt |
8 |
|
rab20 gtpase |
8 |
|
triosephosphate isomerase 1 |
8 |
|
metastasis |
7 |
|
feedback signaling |
6 |
|
nuclear factor kappa b |
6 |
|
nuclear met |
6 |
|
transforming growth factor beta-activated kinase 1 |
6 |
|
von willebrand factor |
6 |
|
apoptosis |
5 |
|
biomarker |
5 |
|
diabetic cardiomyopathy |
5 |
|
glycogen synthase kinase |
5 |
|
heme oxygenase-1 |
5 |
|
janus-activated kinase |
5 |
|
left ventricular hypertrophy |
5 |
|
microrna |
5 |
|
myocardial hypertrophy and dysfunction |
5 |
|
oxidative stress |
5 |
|
propofol |
5 |
|
protein kinase cβ |
5 |
|
protein stability |
5 |
|
remifentanil |
5 |
|
ruboxistaurin |
5 |
|
signal transducer and activator of transcription 3 |
5 |
|
brg1 |
4 |
|
cancers |
4 |
|
clathrin light chain a |
4 |
|
complement factor h |
4 |
|
complement-mediated cytotoxicity |
4 |
|
hepatocellularcarcinoma |
4 |
|
hypoxia-inducible factor-1 |
4 |
|
ischaemia/reperfusion injury |
4 |
|
isoflurane postconditioning |
4 |
|
nrf2 |
4 |
|
pkc-ε |
4 |
|
premetastatic niche |
4 |
|
repeated non-invasive limb ischemic preconditioning |
4 |
|
stat3 |
4 |
|
treatment |
4 |
|
vascular permeability |
4 |
|
arp2/3 |
3 |
|
arpc2 |
3 |
|
biomarkers |
3 |
|
cancer metastasis |
3 |
|
cell motility |
3 |
|
crispr/cas9 |
3 |
|
knockout |
3 |
|
tumor oncology |
3 |
|
cancer |
2 |
|
cancer immunotherapy |
2 |
|
comparative proteomics |
2 |
|
complement |
2 |
|
dc vaccines |
2 |
|
dendritic cells |
2 |
|
diabetes mellitus |
2 |
|
electron transport chain |
2 |
|
energy homeostasis |
2 |
|
ischemia-reperfusion (i/r) injury |
2 |
|
medical sciences |
2 |
|
mitochondrial atp-sensitive potassium channel (mitokatp) |
2 |
|
myocardial reperfusion |
2 |
|
oncology |
2 |
|
postconditioning |
2 |
|
reactive oxygen species |
2 |
|
reperfusion injury |
2 |
|
stemness |
2 |
|
tumour microenvironment |
2 |
|
tumourigenesis |
2 |
